CNS Pharmaceuticals, Inc. (CNSP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.65M | -3.05M | -2.17M | -5.34M | -3.24M | -5.47M | -6.8M | -1.65M | -3.19M | -2.54M | -3.38M | -3.4M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -43.39% | 44.22% | 68.03% | -223.76% | -1.56% | -115.7% | -101.4% | 51.5% | 33.84% | -10.02% | -86.25% | -1.2% |
| Net Income | -4.94M | -5.96M | -3.22M | -2.37M | -4.3M | -3.18M | -5.61M | -2.53M | -3.54M | -5.38M | -4.52M | -4.02M |
| Depreciation & Amortization | 1.87K | 1.02K | 697 | 1.1K | 1.1K | 985 | 751 | 752 | 818 | 953 | 899 | 1K |
| Stock-Based Compensation | 0 | 85.07K | 18.45K | 21.84K | 62.37K | 129.9K | 271.78K | 234.34K | 202.93K | 232.68K | 194.76K | 289.67K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.56K | 3.82M | 0 | 0 | 0 | 0 | -672.19K | 0 | -190 | -259 | 757 | 0 |
| Working Capital Changes | 284K | -999.35K | 1.03M | -2.99M | 995.95K | -2.43M | -794.39K | 645.26K | 149.13K | 2.61M | 950.06K | 327.79K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 577.79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.14K | 0 | 0 | 790.03K |
| Cash from Investing | -6.18K | -18.18K | 0 | 0 | 0 | -4.19K | 0 | 0 | 0 | -2.16K | -1.74K | 0 |
| Capital Expenditures | -6.18K | -18.18K | 0 | 0 | 0 | -4.19K | -3 | 3 | 0 | -2.16K | -1.74K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 3 | -3 | 0 | 0 | 0 | 0 |
| Cash from Financing | 404.66K | 406.87K | -91.62K | 4.43M | 9.83M | 4.96M | 12.28M | 2.33M | 3.46M | 2.18M | 8.36K | 2.57M |
| Debt Issued (Net) | -96.22K | -30.79K | -90.97K | -88.91K | -86.88K | -31.19K | -92.06K | -89.86K | -87.7K | -70.67K | -124.49K | -122.68K |
| Equity Issued (Net) | 500.88K | 501.75K | 844 | 4.51M | 9.03M | 5M | 12.41M | 2.42M | 3.53M | 215.64K | 132.85K | 1.97M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -64.08K | -1.49K | 2.78K | 882.54K | -10K | -40K | -7.83K | 12.4K | 2.03M | 0 | 725.06K |
| Net Change in Cash | -4.25M | -2.66M | -2.27M | -917.72K | 6.59M | -511.75K | 5.48M | 676.33K | 266.5K | -360.83K | -3.37M | -831.28K |
| Free Cash Flow | -4.65M | -3.07M | -2.17M | -5.34M | -3.24M | -5.48M | -6.8M | -1.65M | -3.19M | -2.54M | -3.38M | -3.4M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -43.58% | 43.93% | 68.03% | -223.76% | -1.56% | -115.68% | -101.3% | 51.5% | 33.84% | -10.12% | -86.19% | -1.11% |
| FCF per Share | -6.88 | -6.92 | -3.89 | -14.44 | -14.27 | -46.48 | -183.94 | -2629.11 | -10991.07 | -13517.45 | -24261.48 | -26328.26 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.51x | 0.68x | 2.25x | 0.75x | 1.72x | 1.21x | 0.65x | 0.90x | 0.47x | 0.75x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 4.18K | 0 | 253 | 0 | 0 | 0 | 0 | 0 | 3.65K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |